Rhinovirus-16 induced release of IP-10 and IL-8 is augmented by Th2 cytokines in a pediatric bronchial epithelial cell model

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Cakebread, Julie A ^a,c   Haitchi, Hans Michael ^a   Xu, Yunhe ^a   Holgate, Stephen T ^a,b   Roberts, Graham ^a,b   Davies, Donna E ^a,b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^c RUAKURA RESEARCH CENTRE   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; CYTOKINE;

ADOLESCENT; ARTICLE; BRONCHUS MUCOSA; CHILD; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN RHINOVIRUS A16; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRESCHOOL CHILD; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; SIGNAL TRANSDUCTION; VIRUS REPLICATION; BIOSYNTHESIS; BRONCHUS; DRUG EFFECTS; EPITHELIUM CELL; IMMUNOLOGY; INFANT; INFLAMMATION; METABOLISM; PHYSIOLOGY; RESPIRATORY TRACT MUCOSA; RHINOVIRUS; TH2 CELL; VIROLOGY;

ADOLESCENT; BRONCHI; CHEMOKINE CXCL10; CHILD; CHILD, PRESCHOOL; CYTOKINES; EPITHELIAL CELLS; FEMALE; HUMANS; INFANT; INFLAMMATION; INTERLEUKIN-8; MALE; RESPIRATORY MUCOSA; RHINOVIRUS; SIGNAL TRANSDUCTION; TH2 CELLS; VIRUS REPLICATION;

EID: 84899117575     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094010     Document Type: Article

References (41)

1. Kim HY, DeKruyff RH, Umetsu DT (2010) The many paths to asthma: phenotype shaped by innate and adaptive immunity. Nat Immunol 11: 577-584. ni.1892 [pii];10.1038/ni.1892 [doi].
2. Brightling CE, Symon FA, Birring SS, Bradding P, Pavord ID, et al. (2002) TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis. J Allergy Clin Immunol 110: 899-905. S0091674902014732 [pii].
3. Robinson DS (2000) Th-2 cytokines in allergic disease. Br Med Bull 56: 956-968.
4. Gern JE, Vrtis R, Grindle KA, Swenson C, Busse WW (2000) Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. Am J Respir Crit Care Med 162: 2226-2231. (Pubitemid 32051692)
5. Parry DE, Busse WW, Sukow KA, Dick CR, Swenson C, et al. (2000) Rhinovirus-induced PBMC responses and outcome of experimental infection in allergic subjects. J Allergy Clin Immunol 105: 692-698. S0091-6749(00)36224-8 [pii];10.1067/mai.2000.104785 [doi].
6. Hollams EM, Deverell M, Serralha M, Suriyaarachchi D, Parsons F, et al. (2009) Elucidation of asthma phenotypes in atopic teenagers through parallel immunophenotypic and clinical profiling. J Allergy Clin Immunol 124: 463-70, 470. S0091-6749(09)00952-X [pii];10.1016/j.jaci.2009.06.019 [doi].
7. Sly PD, Boner AL, Bjorksten B, Bush A, Custovic A, et al. (2008) Early identification of atopy in the prediction of persistent asthma in children. Lancet 372: 1100-1106. S0140-6736(08)61451-8 [pii];10.1016/S0140-6736(08)61451-8 [doi].
8. Stern DA, Morgan WJ, Halonen M, Wright AL, Martinez FD (2008) Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study. Lancet 372: 1058-1064. S0140-6736(08)61447-6 [pii];10.1016/S0140-6736(08)61447-6 [doi].
9. Jackson DJ, Johnston SL (2010) The role of viruses in acute exacerbations of asthma. J Allergy Clin Immunol 125: 1178-1187. S0091-6749(10)00689-5 [pii];10.1016/j.jaci.2010.04.021 [doi].
10. Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, et al. (1995) Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 310: 1225-1229.
11. Green RM, Custovic A, Sanderson G, Hunter J, Johnston SL, et al. (2002) Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ 324: 763.
12. Subrata LS, Bizzintino J, Mamessier E, Bosco A, McKenna KL, et al. (2009) Interactions between innate antiviral and atopic immunoinflammatory pathways precipitate and sustain asthma exacerbations in children. J Immunol 183: 2793-2800. jimmunol.0900695 [pii];10.4049/jimmunol.0900695 [doi].
13. Bulek K, Swaidani S, Aronica M, Li X (2010) Epithelium: the interplay between innate and Th2 immunity. Immunol Cell Biol 88: 257-268. icb2009113 [pii];10.1038/icb.2009.113 [doi].
14. Bianco A, Sethi SK, Allen JT, Knight RA, Spiteri MA (1998) Th2 cytokines exert a dominant influence on epithelial cell expression of the major group human rhinovirus receptor, ICAM-1. Eur Respir J 12: 619-626. (Pubitemid 28420141)
15. Papi A (1997) Epithelial ICAM-1 regulation and its role in allergy. Clin Exp Allergy 27: 721-724.
16. Hurd SZ (1991) Workshop summary and guidelines: investigative use of bronchoscopy, lavage, and bronchial biopsies in asthma and other airway diseases. J Allergy Clin Immunol 88: 808-814.
17. Bucchieri F, Puddicombe SM, Lordan JL, Richter A, Buchanan D, et al. (2002) Asthmatic bronchial epithelium is more susceptible to oxidant-induced apoptosis. Am J Respir Cell Mol Biol 27(2): 179-185. (Pubitemid 34780797)
18. Papi A, Johnston SL (1999) Rhinovirus infection induces expression of its own receptor intercellular adhesion molecule 1 (ICAM-1) via increased NF-kappaB-mediated transcription. J Biol Chem 274: 9707-9720.
19. Andrews AL, Nasir T, Bucchieri F, Holloway JW, Holgate ST, et al. (2006) IL-13 receptor alpha 2: a regulator of IL-13 and IL-4 signal transduction in primary human fibroblasts. J Allergy Clin Immunol 118: 858-865. (Pubitemid 44515110)
20. Bossios A, Psarras S, Gourgiotis D, Skevaki CL, Constantopoulos AG, et al. (2005) Rhinovirus infection induces cytotoxicity and delays wound healing in bronchial epithelial cells. Respir Res 6: 114.
21. Vlahos CJ, Matter WF, Hui KY, Brown RF (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269: 5241-5248.
22. Kumar S, Jiang MS, Adams JL, Lee JC (1999) Pyridinylimidazole compound SB 203580 inhibits the activity but not the activation of p38 mitogen-activated protein kinase. Biochem Biophys Res Commun 263: 825-831. 10.1006/bbrc.1999.1454 [doi];S0006-291X(99)91454-7 [pii].
23. Chang MM, Juarez M, Hyde DM, Wu R (2001) Mechanism of dexamethasone-mediated interleukin-8 gene suppression in cultured airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 280: L107-L115.
24. Hu L, Zaloudek C, Mills GB, Gray J, Jaffe RB (2000) In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002). Clin Cancer Res 6: 880-886. (Pubitemid 30159344)
25. Griego SD, Weston CB, Adams JL, Tal-Singer R, Dillon SB (2000) Role of p38 mitogen-activated protein kinase in rhinovirus-induced cytokine production by bronchial epithelial cells. J Immunol 165: 5211-5220.
26. Edwards MR, Johnson MW, Johnston SL (2006) Combination therapy: Synergistic suppression of virus-induced chemokines in airway epithelial cells. Am J Respir Cell Mol Biol 34: 616-624. 2005-0385OC [pii];10.1165/rcmb.2005- 0385OC [doi].
27. Skevaki CL, Christodoulou I, Spyridaki IS, Tiniakou I, Georgiou V, et al. (2009) Budesonide and formoterol inhibit inflammatory mediator production by bronchial epithelial cells infected with rhinovirus. Clin Exp Allergy 39: 1700-1710. CEA3307 [pii];10.1111/j.1365-2222.2009.03307.x [doi].
28. Wark PA, Bucchieri F, Johnston SL, Gibson PG, Hamilton L, et al. (2007) IFN-gamma-induced protein 10 is a novel biomarker of rhinovirus-induced asthma exacerbations. J Allergy Clin Immunol 120: 586-593. S0091-6749(07)01025-1 [pii];10.1016/j.jaci.2007.04.046 [doi].
29. Korpi-Steiner NL, Valkenaar SM, Bates ME, Evans MD, Gern JE, et al. (2010) Human monocytic cells direct the robust release of CXCL10 by bronchial epithelial cells during rhinovirus infection. Clin Exp Allergy 40: 1203-1213. CEA3546 [pii];10.1111/j.1365-2222.2010.03546.x [doi].
30. Lachowicz-Scroggins ME, Boushey HA, Finkbeiner WE, Widdicombe JH (2010) Interleukin-13-induced mucous metaplasia increases susceptibility of human airway epithelium to rhinovirus infection. Am J Respir Cell Mol Biol 43: 652-661. 2009-0244OC [pii];10.1165/rcmb.2009-0244OC [doi].
31. Xatzipsalti M, Psarros F, Konstantinou G, Gaga M, Gourgiotis D, et al. (2008) Modulation of the epithelial inflammatory response to rhinovirus in an atopic environment. Clin Exp Allergy 38: 466-472. CEA2906 [pii];10.1111/j.1365- 2222.2007.02906.x [doi].
32. Jakiela B, Brockman-Schneider R, Amineva S, Lee WM, Gern JE (2008) Basal cells of differentiated bronchial epithelium are more susceptible to rhinovirus infection. Am J Respir Cell Mol Biol 38: 517-523. (Pubitemid 351758669)
33. Grunig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, et al. (1998) Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282: 2261-2263. (Pubitemid 29004075)
34. Striz I, Mio T, Adachi Y, Heires P, Robbins RA, et al. (1999) IL-4 induces ICAM-1 expression in human bronchial epithelial cells and potentiates TNF-alpha. Am J Physiol 277: L58-L64. (Pubitemid 29356751)
35. Puddicombe SM, Polosa R, Richter A, Krishna MT, Howarth PH, et al. (2000) Involvement of the epidermal growth factor receptor in epithelial repair in asthma. FASEB J 14: 1362-1374. (Pubitemid 30439745)
36. Subauste MC, Jacoby DB, Richards SM, Proud D (1995) Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest 96: 549-557. 10.1172/JCI118067 [doi].
37. Lordan JL, Bucchieri F, Richter A, Konstantinidis A, Holloway JW, et al. (2002) Cooperative effects of Th2 cytokines and allergen on normal and asthmatic bronchial epithelial cells. J Immunol 169: 407-414. (Pubitemid 34686162)
38. Wood LG, Powell H, Grissell TV, Davies B, Shafren DR, et al. (2011) Persistence of rhinovirus RNA and IP-10 gene expression after acute asthma. Respirology 16: 291-299. 10.1111/j.1440-1843.2010.01897.x [doi].
39. Liu P, Cheng H, Roberts TM, Zhao JJ (2009) Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov 8: 627-644. nrd2926 [pii];10.1038/nrd2926 [doi].
40. Marone R, Cmiljanovic V, Giese B, Wymann MP (2008) Targeting phosphoinositide 3-kinase: moving towards therapy. Biochim Biophys Acta 1784: 159-185. S1570-9639(07)00260-9 [pii];10.1016/j.bbapap.2007.10.003 [doi].
41. Walker EH, Pacold ME, Perisic O, Stephens L, Hawkins PT, et al. (2000) Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell 6: 909-919. S1097-2765(05)00089-4 [pii].